Founder of Fit Body Boot Camp Launches Breakthrough Glute Workout Device

Glute Workout Device:

Steve Hochman, renowned southern California trainer and co-founder of Fit Body Boot Camp, has invented the first wearable glute-activating device, now available through crowdfunding on Indiegogo. Check it out here!

“After training thousands of clients over the past 20 years, I discovered that 90 percent of people struggle to activate their glutes,” said Hochman. “The GX5 TRAINER’s patent-pending design redirects your body’s energy allowing your glutes to work up to 87% more.”
The set straps to your shoe for maximum glute activation, form correction, and pain alleviation during all lower body workouts. The GX5 TRAINER™ is the only wearable product on the market that corrects your form during both stationary and moving exercises, such as walking lunges.

By purchasing the GX5 TRAINER™, you will also receive free access to the GX5 FIT app featuring:

6 Week Booty Lift Series
How-to library for popular glute exercises
Live and recorded GX5 glute classes

“We believe this product has the potential to take off on a global scale,” said Hochman. “The GX5 TRAINER™ is ready for mass-production, but we need more capital to really make a splash in the U.S. health and fitness market. We’ve decided to launch the product with Indiegogo, a platform to fund ingenious, work-in-progress products and ideas. We’re ready for mass production and we will begin shipping in June!”

SourceGX5 FIT

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”